Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma
Yoshihiro Otani(Okayama University), Yeshavanth Banasavadi‐Siddegowda(Neurological Surgery), Sadhana Jackson(National Institutes of Health), Guruprasad Rachaiah(Karnataka Veterinary Animal and Fisheries Sciences University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Yuanqing Yan(Northwestern University), Balveen Kaur(Augusta University), Amélie Vézina(The University of Texas Health Science Center at Houston), John D. Heiss(National Institutes of Health), Cole T. Lewis(The University of Texas Health Science Center), Ashis Chowdhury(The University of Texas Health Science Center at Houston), Arunakumar Gangaplara(National Institutes of Health), Leomar Y. Ballester(The University of Texas MD Anderson Cancer Center), Dragan Maric(National Institute of Neurological Disorders and Stroke), Sriya Namagiri(National Institutes of Health), Toshihiko Shimizu(The University of Texas Health Science Center), Prashant Chittiboina(National Institutes of Health), Xiang Wang(Chenzhou First People's Hospital), Sachin Kumar(Shree Guru Gobind Singh Tricentenary University), Abhik Ray‐Chaudhury(National Institutes of Health), Zhuang Zhengping(National Institutes of Health), Hannah Sur(National Institutes of Health)
Cited by 34
Related Papers
Microvascular Injury in the Brains of Patients with Covid-19
|New England Journal of Medicine|2020|603
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast
|Proceedings of the National Academy of Sciences|2010|433
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
|Cell stem cell|2018|423